Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.

Jiang, Zhengyu; Wu, Feijing; Laise, Pasquale; Takayuki, Tanaka; Na, Fu; Kim, Woosook; Kobayashi, Hiroki; Chang, Wenju et al. · Cell Stem Cell · 2023

basic_science · Level V

Where this comes from

Abstract

While adult pancreatic stem cells are thought not to exist, it is now appreciated that the acinar compartment harbors progenitors, including tissue-repairing facultative progenitors (FPs). Here, we study a pancreatic acinar population marked by trefoil factor 2 (Tff2) expression. Long-term lineage tracing and single-cell RNA sequencing (scRNA-seq) analysis of Tff2-DTR-CreER<sup>T2</sup>-targeted cells defines a transit-amplifying progenitor (TAP) population that contributes to normal homeostasis. Following acute and chronic injury, Tff2<sup>+</sup> cells, distinct from FPs, undergo depopulation but are eventually replenished. At baseline, oncogenic Kras<sup>G12D</sup>-targeted Tff2<sup>+</sup> cells are resistant to PDAC initiation. However, Kras<sup>G12D</sup> activation in Tff2<sup>+</sup> cells leads to survival and clonal expansion following pancreatitis and a cancer stem/progenitor cell-like state. Selective ablation of Tff2<sup>+</sup> cells prior to Kras<sup>G12D</sup> activation in Mist1<sup>+</sup> acinar or Dclk1<sup>+</sup> FP cells results in enhanced tumorigenesis, which can be partially rescued by adenoviral Tff2 treatment. Together, Tff2 defines a pancreatic TAP population that protects against Kras-driven carcinogenesis.

Medical subject headings